Affimed NV (Affimed NV) Other Gross PPE : $0.06 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Affimed NV Other Gross PPE?

Affimed NV's Other Gross PPE for the quarter that ended in Dec. 2023 was $0.06 Mil.

Affimed NV's quarterly Other Gross PPE increased from Jun. 2023 ($4.15 Mil) to Sep. 2023 ($14.51 Mil) but then declined from Sep. 2023 ($14.51 Mil) to Dec. 2023 ($0.06 Mil).

Affimed NV's annual Other Gross PPE declined from Dec. 2021 ($1.18 Mil) to Dec. 2022 ($0.08 Mil) and declined from Dec. 2022 ($0.08 Mil) to Dec. 2023 ($0.06 Mil).

Affimed NV Other Gross PPE Historical Data

The historical data trend for Affimed NV's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Other Gross PPE Chart

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

3.46

1.23

1.18

0.08

0.06

Affimed NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															0.08	4.40	4.15	14.51	0.06

Affimed NV Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Affimed NV (Affimed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

A28:Germany

Address

Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.